A sigh of relief for Boston, as Cameron's leadless ICD gets FDA panel thumbs up
This article was originally published in Clinica
Executive Summary
An FDA advisory panel has voted in favour of Cameron Health's subcutaneous implantable cardioverter defibrillator (S-ICD), paving the way for its approval in the US. The positive panel decision is somewhat surprising; earlier this week the agency released a report flagging up a risk of infection and inappropriate shocks with the device.